Dr. Joseph Maroon’s Keynote address to the 14th Annual International Hyperbarics Association (IHA) Meeting

June 2023 Hollywood, Florida – Neurosurgeon Dr. Joseph Maroon was the Keynote Speaker at the 14th Annual International Hyperbarics Association (IHA) Meeting. Dr. Maroon reviewed many of the neurological application that are being investigated and gives background information of many of his own experiences with hyperbaric oxygen therapy. (SEE VIDEO OF DR. MAROON’S LECTURE BELOW)

Read an excerpt of Dr. Maroon’s July 2022, Frontiers in Neurology article, entitled, The effect of hyperbaric oxygen therapy on cognition, performance, proteomics, and
telomere length—The difference between zero and one: A case report
Joseph C. Maroon*

Hyperbaric oxygen (HBO2) therapy is one idea that has been
FDA approved and is efficacious in the treatment of 13 different
medical conditions including decompression sickness, nonhealing
wounds, severe anemia, carbon monoxide poisoning,
among others (2). It also has been used off label for closed head
injuries, post-stroke, post-traumatic stress syndrome (PTSD)
and post-concussion syndrome (PCS) (3–7). Numerous HBO2
therapy mechanisms have been shown in both preclinical
and clinical models including anti-inflammatory effects, stem
cells recruitment, angiogenesis, neurogenesis, increased cerebral
blood flow, mitochondrial function restoration, and cellular
metabolism. By supplying repeated hyperoxic exposures, the
hyperoxic-hypoxic paradox is utilized, increasing HIF-1a levels
along with tissues hyperoxygenation (8–10). Recently, HBO2
therapy was shown to induce both cognitive and physical
performance enhancements in healthy aging adults (11, 12).
For 8 years, I have used HBO2 therapy to treat patients with
PCS when all other treatment modalities had failed. Impressed
with the results, I recently carried out a self-experiment to
obtain objective information on the effects of HBO2 therapy
on neurocognition, cardiopulmonary function, neuroimaging,
telomere length, proteomics, among other objective measures


Reference:

Maroon JC (2022) The effect of hyperbaric oxygen therapy on cognition, performance, proteomics, and telomere length—The difference between zero and one: A case report. Front. Neurol. 13:949536. doi: 10.3389/fneur.2022.949536